Clinical trial
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability…
NCT02357901 · Indivior Inc., Industry · Completed
Key facts
| NCT number | NCT02357901 |
|---|---|
| Title | Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess the Efficacy, Safety, and Tolerability of Multiple Subcutaneous Injections of Depot Buprenorphine (RBP-6000 [100 mg and 300 mg]) Over 24 Weeks in Treatment-Seeking Subjects With Opioid Use Disorder |
| Lead sponsor | Indivior Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Opioid Dependence, Opioid Related Disorders |
| Intervention type | Drug |
| Interventions | SUBOXONE, RBP-6000, Placebo |
| Enrollment | 665 |
| Start date | Jan 28, 2015 |
| Primary completion | Apr 29, 2016 |
| Completion | Apr 29, 2016 |
| First posted | Feb 6, 2015 |
| Last update posted | Feb 20, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: